Search results

Selected filters:

Law & Policy

Article type

Topic

Sector

Regions

2,404 results found for your search

Sort options
24 April 2019

The US Supreme Court's biggest patent case this year has nothing to do with patents

A low-profile veterans dispute could shift the law on deference with major implications for all parts of the executive branch - including the USPTO

23 April 2019

US patent litigation is down, but not for Korean companies

South Korean government study also shows that NPEs continue to target foreign defendants in places like Marshall, Texas (pictured) post TC Heartland

23 April 2019

Why Iancu has not been a cheerleader for 101 reform on the Hill

USPTO director appears to be focused on what he can control and less on a legislative fix that could be years in the making

19 April 2019

New framework for US patent eligibility reform runs into familiar problems

At a well-attended Washington DC meeting on Wednesday, key stakeholders struggled to get past a series of issues that have consistently hampered attempts to deliver changes to Section 101 via Congress

18 April 2019

Why Ericsson’s licensing practices are under investigation in China

Executives at some of the country's leading domestic mobile manufacturers open up about the reasons they believe an anti-trust investigation of the Swedish company is merited

16 April 2019

How Europe and China handle blockchain patents

As this disruptive technology attracts increasing interest, key issuing authorities are developing different ways of handling applications that read on it

15 April 2019

China is investigating Ericsson’s patent licensing business, company confirms

A surprise inspection at the Swedish giant’s Beijing office sets the stage for the first big IP probe by China’s new super-regulator

12 April 2019

Controversial EPO patentability intervention is unlikely to succeed, experts claim

Attorneys say agency’s president has no legal basis for asking the Enlarged Board of Appeal to review the finding that plants produced by biological processes are patentable.

11 April 2019

One year on from the<em> SAS </em>decision practitioners mull its impact on the PTAB

In a period of marked change at the board, early numbers suggest the Supreme Court’s landmark decision is leading to greater discretion among petitioners

09 April 2019

'Reverse patent trolls' plague big pharma in China

The high invalidation rate for life science patents in China has created a headache for drug companies and a money-making opportunity for enterprising individuals

08 April 2019

The current cost of transparency in IoT patent licensing

Two senior members of the Ericsson IP team argue that innovators involved in wireless standardisation currently face impossible choices that lead to over-declaration or potential loss of enforceability

08 April 2019

Despite Iancu message to relook at Supreme Court precedent CAFC knocks out another medical diagnostics patent on 101

With outline of proposed subject matter eligibility bill expected this month latest key Federal Circuit ruling ratchets up the pressure on Congressional action  

08 April 2019

Reforms seek to boost South Korea's patent market

Firms welcomed tougher measures against infringers at IPBC Korea 2019 last week, but there are concerns about a recent initiative to attract more foreign litigants through the use of English-language hearings

06 April 2019

The big biopharma patent developments in March

Everything you need to know about the major news stories in the life sciences sector that broke last month

05 April 2019

UK Supreme Court confirms dosage regimens are patentable

Judges rule that inventions arrived at by well-established or routine tests can be patented, but the decision will also reassure generics